
Ladan Zand
@ladanzand
Nephrologist. Interested in GN.
ID: 1166145581884039171
27-08-2019 00:29:26
648 Tweet
1,1K Takipรงi
294 Takip Edilen


Fast forward to 2025 โฉ Long-term Outcome of Adult Patients with Membranous Nephropathy treated with Rituximab from KIReports fernando fervenza Ladan Zand Sanjeev Sethi Maria Jose Soler Ilario Russo, MD Gian Marco Berti Anila Cara #Nephpearls ๐ข For context, see quoted tweet from




1. Is this MGRS? This is common when we see CKD patients with monoclonal gammopathy? Our work in KI can aid clinician in this situation! Let's dive in this paper! kidney-international.org/article/S0085-โฆ Ladan Zand fernando fervenza Sanjeev Sethi Mayo Clinic Nephrology UMN Division of Nephrology & Hypertension American Society of Onconephrology


The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy Ladan Zand Nattawat Klomjit maria jose vargas Sanjeev Sethi fernando fervenza kidney-international.org/article/S0085-โฆ

Clinicopathological Characteristics and Long-Term Kidney Outcomes in Biopsy-Proven Renal Sarcoidosis Jing ^_^ Wisit Cheungpasitporn MD FACP | FASN | FAST Ladan Zand fernando fervenza ASN Publications journals.lww.com/kidney360/abstโฆ




Do you have crescentic IgA Nephropathy? You may qualify for a Mayo Clinic clinical trial evaluating a novel treatment for crescentic IgAN. โAvacopan in Crescentic IgANโ Learn more and see if you are eligible: Link ๐ mayo.edu/research/cliniโฆ fernando fervenza Ladan Zand

Clinical trial at our Mayo Clinic Nephrology: Evaluating daratumumab for treatment of PGNMID (Proliferative Glomerulonephritis with Monoclonal Immune Deposits). A novel approach to a rare glomerular disease. fernando fervenza Ladan Zand Learn More๐ mayo.edu/research/cliniโฆ

๐ฅ๐ฅ๐ฅ โ๐๐ซ๐ฌ๐ญ ๐๐๐ฒ๐จ ๐๐ฅ๐ข๐ง๐ข๐ - ๐๐๐ฅ๐ฅ ๐โ๐๐๐๐ซ๐จ๐ง ๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐โ save the dates 5-6 Sep Barcelona 2025. Register to [email protected] organized by Mayo Clinic Nephrology Nefrologia Hospital Universitari Vall d'Hebron Vall d'Hebron Sandra Herrmann MD, FASN oriol bestard fernando fervenza

In this multi-center study we describe 3 distinct phenotypes of patients with PLA2R-MN using unsupervised machine learning! โฆJing ^_^โฉ fernando fervenzaโฉ โฆShane Bobart, MD, FASNโฉ โฆWisit Cheungpasitporn MD FACP | FASN | FASTโฉ โฆMaria Jose Solerโฉ โฆNDTโฉ academic.oup.com/ndt/advance-arโฆ

๐ฅ๐ฅ๐ฅ โ๐๐ซ๐ฌ๐ญ ๐๐๐ฒ๐จ ๐๐ฅ๐ข๐ง๐ข๐ - ๐๐๐ฅ๐ฅ ๐โ๐๐๐๐ซ๐จ๐ง ๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐โ 5-6 Sep Barcelona 2025. Register to [email protected] Mayo Clinic Nephrology Nefrologia Hospital Universitari Vall d'Hebron Vall d'Hebron Sandra Herrmann MD, FASN oriol bestard fernando fervenza Ladan Zand #andreaKattah